Michelle Robertson
About Michelle Robertson
Michelle Robertson serves as the Chief Financial Officer at Geron Corporation and has extensive experience in the biotechnology sector, including previous roles at Genzyme Corporation and Editas Medicine. She specializes in long-term strategy planning, acquisition analysis, and business process management.
Current Role at Geron Corporation
Michelle Robertson serves as the Chief Financial Officer at Geron Corporation, a position she has held since 2023. In this role, she oversees the financial operations and strategic financial planning of the company, contributing to its growth and stability within the biotechnology sector. Her responsibilities include financial reporting, budgeting, and ensuring compliance with regulatory requirements. Geron Corporation is based in Foster City, California, and focuses on developing innovative therapies for cancer treatment.
Previous Experience at Genzyme Corporation
Prior to her current role, Michelle Robertson worked at Genzyme Corporation from 1995 to 2011. She held various positions, culminating in her role as Vice President of Commercial Operations. During her 16 years at Genzyme, she developed a strong foundation in finance and operations within the biotechnology industry. Her experience included senior financial management and strategic planning, which contributed to the company's growth and success.
Professional Background in Biotechnology
Michelle Robertson has extensive experience in the biotechnology field, having held key financial positions at several companies. She was the Chief Financial Officer at Editas Medicine from 2020 to 2023 and served as Vice President Finance - Oncology at Baxalta from 2015 to 2016. Additionally, she worked at Momenta Pharmaceuticals in various roles, including CFO & Treasurer from 2018 to 2020 and Vice President FP&A from 2017 to 2018. Her background includes expertise in acquisition analysis, long-term strategy planning, and business process management.
Education and Expertise
Michelle Robertson studied at Bentley University, where she earned a Bachelor of Science in Finance and an Associate of Science in Accounting and Management from 1984 to 1988. Her educational background has provided her with a solid foundation in financial principles and practices. She is recognized for her ability to implement innovative systems and processes within the biotechnology industry, as well as her experience in third-party logistics (3PL) management and distribution.
Leadership Roles and Contributions
In addition to her role at Geron Corporation, Michelle Robertson has been a Board member and Audit Committee Chair at Verastem Oncology since 2021. She is also a Chief Member, a position she has held since 2022. Her leadership roles demonstrate her commitment to advancing financial strategies and governance in the biotechnology sector, as well as her ability to collaborate effectively with various stakeholders, including customers, vendors, and management.